PepGen Inc. (PEPG) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $1.31 - $7.80

4.5 Year PEPG Performance Metrics:

Total Return (with DRIP): -80.9% (-30.82% CAGR)

Total Return (no DRIP): -78.4% (-28.89% CAGR)

Share Price: -81.7% (-31.43% CAGR)

Yield on Cost (with DRIP): 3.39%

Total Invested: $10,000

Total Value (with DRIP): $1,905

Total Return $ (with DRIP): -$8,095

Dividend Increase: 0.0% (0.00% CAGR)

Dividend Yield (FWD): 0.00% ($0.00)

PEPG 4.5-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

PEPG Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

PEPG Price CAGR:1Y: -47.90%2Y: -42.22%5Y: -31.52%10Y: -31.52%

PEPG Dividend Payments & Yield

Dividend Payments & Yield

PEPG Dividend CAGR:1Y: 40.00%2Y: 24.72%5Y: 28.47%10Y: 18.20%

Annual Dividends (Total Paid Per Year)

Dividend Growth Year Over Year

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

PEPG Dividends Info:

Annual Dividend: $0.42

Forward Yield: 17.8%

Ex-Dividend Date: 2022-05-23

Lifetime Dividends / Share: $1.51

PEPG Dividend History: Dates, Payments & Yield list

Below is a schedule of all PEPG dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
05/23/2022	05/25/2022	$0.420	4.56%	4.06%	$10.35
05/20/2019	05/22/2019	$0.300	0%	0%	$0.00
05/21/2018	05/23/2018	$0.270	0%	0%	$0.00
05/22/2017	05/24/2017	$0.160	0%	0%	$0.00
05/23/2016	05/25/2016	$0.130	0%	0%	$0.00
05/18/2015	05/20/2015	$0.120	0%	0%	$0.00
05/19/2014	05/21/2014	$0.110	0%	0%	$0.00

Projected Future Returns & Dividends for PEPG

Based on past 4.5-year performance, here are PEPG growth metrics:

Share price CAGR of -31.43%
Dividend CAGR of +18.2%

Using PEPG CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	PEPG (DRIP)	PEPG - No DRIP
Current Price	$2.36	$2.36
Start Shares	4,237.29	4,237.29
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	21,797.96	4,237.29
Dividends Payment	$0.01	$0.01
Annual Dividends	$210	$41
Yield on cost	2.10%	0.41%
Share Price	$0.05	$0.05
Total Dividends	$8,163	$5,532
Final Value	$1,182	$5,762

Estimated Future Value + Dividends - PEPG

NOTE: Above numbers are our estimate based on PEPG's Dividend and Price CAGR over past 4.5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Company Info

PepGen Inc. (PEPG) had its IPO on , and is traded on NASDAQ stock exchange.

PepGen Inc. is a clinical-stage biotechnology company focused on developing oligonucleotide therapeutics for severe neuromuscular and neurologic diseases. The company’s work centers on its proprietary Enhanced Delivery Oligonucleotide platform, which is designed to improve the delivery, uptake, and activity of conjugated oligonucleotide medicines in targeted tissues. PepGen’s current pipeline includes investigational programs for conditions such as Duchenne muscular dystrophy and myotonic dystrophy type 1, with several candidates in clinical development and additional programs in earlier stages. By concentrating on genetic disorders with high unmet medical need, PepGen aims to advance precision therapeutics that address the underlying cause of disease rather than only managing symptoms. The company is headquartered in Boston, Massachusetts.

PEPG website: https://www.pepgen.com